{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T06:51:53Z","timestamp":1792651913982,"version":"4.5.0"},"reference-count":53,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,10,7]],"date-time":"2023-10-07T00:00:00Z","timestamp":1696636800000},"content-version":"vor","delay-in-days":371,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1016\/j.bbadis.2022.166480","type":"journal-article","created":{"date-parts":[[2022,7,8]],"date-time":"2022-07-08T02:07:38Z","timestamp":1657246058000},"page":"166480","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["Macrophage-specific MyD88 deletion and pharmacological inhibition prevents liver damage in non-alcoholic fatty liver disease via reducing inflammatory response"],"prefix":"10.1016","volume":"1868","author":[{"given":"Bin","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wu","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minxiu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yelin","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiwei","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leiming","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meihong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-jiang","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunjie","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guang","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.bbadis.2022.166480_bb0005","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1038\/ncpgasthep0084","article-title":"Mechanisms of disease: pathogenesis of nonalcoholic fatty liver disease","volume":"2","author":"Sanyal","year":"2005","journal-title":"Nat. Clin. Pract. Gastroenterol. Hepatol."},{"issue":"1","key":"10.1016\/j.bbadis.2022.166480_bb0010","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/hep.29367","article-title":"The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases","volume":"67","author":"Chalasani","year":"2018","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.bbadis.2022.166480_bb0015","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1002\/hep.29466","article-title":"Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease","volume":"67","author":"Estes","year":"2018","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.bbadis.2022.166480_bb0020","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1038\/nrgastro.2010.50","article-title":"NASH: thiazolidinediones for NASH\u2013one pill doesn't fix everything","volume":"7","author":"Neuschwander-Tetri","year":"2010","journal-title":"Nat. Rev. Gastroenterol. Hepatol. Hepatol."},{"issue":"4","key":"10.1016\/j.bbadis.2022.166480_bb0025","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1111\/imm.12451","article-title":"Tissue-resident macrophages: then and now","volume":"144","author":"Davies","year":"2015","journal-title":"Immunology"},{"issue":"1","key":"10.1016\/j.bbadis.2022.166480_bb0030","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/s41423-020-00558-8","article-title":"Hepatic macrophages in liver homeostasis and diseases-diversity, plasticity and therapeutic opportunities","volume":"18","author":"Wen","year":"2021","journal-title":"Cell. Mol. Immunol."},{"issue":"1","key":"10.1016\/j.bbadis.2022.166480_bb0035","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1002\/hep.29777","article-title":"Disruption of adenosine 2A receptor exacerbates NAFLD through increasing inflammatory responses and SREBP1c activity","volume":"68","author":"Cai","year":"2018","journal-title":"Hepatology (Baltimore, Md)"},{"issue":"3","key":"10.1016\/j.bbadis.2022.166480_bb0040","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1124\/pr.108.00001","article-title":"Molecular mechanisms and therapeutic targets in steatosis and steatohepatitis","volume":"60","author":"Anderson","year":"2008","journal-title":"Pharmacol. Rev."},{"issue":"4","key":"10.1016\/j.bbadis.2022.166480_bb0045","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1002\/hep.26937","article-title":"The portal inflammatory infiltrate and ductular reaction in human nonalcoholic fatty liver disease","volume":"59","author":"Gadd","year":"2014","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.bbadis.2022.166480_bb0050","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1016\/j.jhep.2013.12.025","article-title":"Macrophage heterogeneity in liver injury and fibrosis","volume":"60","author":"Tacke","year":"2014","journal-title":"J. Hepatol."},{"issue":"6","key":"10.1016\/j.bbadis.2022.166480_bb0055","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1053\/j.gastro.2018.09.010","article-title":"Expression of STING is increased in liver tissues from patients with NAFLD and promotes macrophage-mediated hepatic inflammation and fibrosis in mice","volume":"155","author":"Luo","year":"2018","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1016\/j.bbadis.2022.166480_bb0060","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1002\/hep.32213","article-title":"Switch-associated protein 70 protects against nonalcoholic fatty liver disease via suppression of TAK1","volume":"75","author":"Qian","year":"2021","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.bbadis.2022.166480_bb0065","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.jhep.2007.04.019","article-title":"Toll-like receptor-4 signaling and kupffer cells play pivotal roles in the pathogenesis of non-alcoholic steatohepatitis","volume":"47","author":"Rivera","year":"2007","journal-title":"J. Hepatol."},{"issue":"11","key":"10.1016\/j.bbadis.2022.166480_bb0070","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1038\/nm1663","article-title":"TLR4 enhances TGF-beta signaling and hepatic fibrosis","volume":"13","author":"Seki","year":"2007","journal-title":"Nat. Med."},{"issue":"3","key":"10.1016\/j.bbadis.2022.166480_bb0075","article-title":"Nano-enabled reposition of proton pump inhibitors for TLR inhibition: toward a new targeted nanotherapy for acute lung injury","volume":"9","author":"Sun","year":"2022","journal-title":"Adv. Sci. (Weinh.)"},{"issue":"11 Suppl","key":"10.1016\/j.bbadis.2022.166480_bb0080","first-page":"140S","article-title":"Modulation of non-alcoholic steatohepatitis by pattern recognition receptors in mice: the role of toll-like receptors 2 and 4","volume":"29","author":"Szabo","year":"2005","journal-title":"Alcohol. Clin. Exp. Res."},{"issue":"1","key":"10.1016\/j.bbadis.2022.166480_bb0085","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1053\/j.gastro.2010.03.052","article-title":"Toll-like receptor 9 promotes steatohepatitis by induction of interleukin-1beta in mice","volume":"139","author":"Miura","year":"2010","journal-title":"Gastroenterology"},{"issue":"6851","key":"10.1016\/j.bbadis.2022.166480_bb0090","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/35092578","article-title":"Mal (MyD88-adapter-like) is required for toll-like receptor-4 signal transduction","volume":"413","author":"Fitzgerald","year":"2001","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.bbadis.2022.166480_bb0095","doi-asserted-by":"crossref","first-page":"417","DOI":"10.33594\/000000228","article-title":"Leptin resistance in the ovary of obese mice is associated with profound changes in the transcriptome of cumulus cells","volume":"54","author":"Wolodko","year":"2020","journal-title":"Cell. Physiol. Biochem."},{"issue":"2","key":"10.1016\/j.bbadis.2022.166480_bb0100","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1111\/liv.12442","article-title":"Expression of toll-like receptors 1\u20135 but not TLR 6\u201310 is elevated in livers of patients with non-alcoholic fatty liver disease","volume":"35","author":"Kanuri","year":"2015","journal-title":"Liver Int."},{"issue":"22","key":"10.1016\/j.bbadis.2022.166480_bb0105","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222212413","article-title":"MyD88 in macrophages enhances liver fibrosis by activation of NLRP3 inflammasome in HSCs","volume":"22","author":"Ge","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.bbadis.2022.166480_bb0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.xpro.2020.100086","article-title":"Protocol for primary mouse hepatocyte isolation","volume":"1","author":"Charni-Natan","year":"2020","journal-title":"STAR Protoc."},{"issue":"1","key":"10.1016\/j.bbadis.2022.166480_bb0115","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1136\/gut.2004.042127","article-title":"Human hepatic stellate cell lines, LX-1 and LX-2: new tools for analysis of hepatic fibrosis","volume":"54","author":"Xu","year":"2005","journal-title":"Gut"},{"issue":"3","key":"10.1016\/j.bbadis.2022.166480_bb0120","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1111\/j.1476-5381.2012.01854.x","article-title":"Inhibition of high glucose-induced inflammatory response and macrophage infiltration by a novel curcumin derivative prevents renal injury in diabetic rats","volume":"166","author":"Pan","year":"2012","journal-title":"Br. J. Pharmacol."},{"issue":"6","key":"10.1016\/j.bbadis.2022.166480_bb0125","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1002\/hep.20701","article-title":"Nonalcoholic steatohepatitis clinical research N. Design and validation of a histological scoring system for nonalcoholic fatty liver disease","volume":"41","author":"Kleiner","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.bbadis.2022.166480_bb0130","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.738731","article-title":"Leptin signaling in the ovary of diet-induced obese mice regulates activation of NOD-like receptor protein 3 inflammasome","volume":"9","author":"Adamowski","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"issue":"3","key":"10.1016\/j.bbadis.2022.166480_bb0135","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1136\/gutjnl-2011-300304","article-title":"Pharmacological inhibition of the chemokine CCL2 (MCP-1) diminishes liver macrophage infiltration and steatohepatitis in chronic hepatic injury","volume":"61","author":"Baeck","year":"2012","journal-title":"Gut"},{"issue":"4","key":"10.1016\/j.bbadis.2022.166480_bb0140","doi-asserted-by":"crossref","first-page":"G483","DOI":"10.1152\/ajpgi.00213.2017","article-title":"CC chemokine receptor 2 promotes recruitment of myeloid cells associated with insulin resistance in nonalcoholic fatty liver disease","volume":"314","author":"Parker","year":"2018","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"issue":"4","key":"10.1016\/j.bbadis.2022.166480_bb0145","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1023\/A:1008942828960","article-title":"Conditional gene targeting in macrophages and granulocytes using LysMcre mice","volume":"8","author":"Clausen","year":"1999","journal-title":"Transgenic Res."},{"issue":"1","key":"10.1016\/j.bbadis.2022.166480_bb0150","doi-asserted-by":"crossref","first-page":"6489","DOI":"10.1038\/s41598-020-63579-3","article-title":"Hepatocyte-specific deletion of pparalpha promotes NAFLD in the context of obesity","volume":"10","author":"Regnier","year":"2020","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.bbadis.2022.166480_bb0155","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1002\/hep.22710","article-title":"C-Jun N-terminal kinase signaling in the pathogenesis of nonalcoholic fatty liver disease: multiple roles in multiple steps","volume":"49","author":"Kodama","year":"2009","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.bbadis.2022.166480_bb0160","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1186\/s12944-017-0551-1","article-title":"Free fatty acids profile among lean, overweight and obese non-alcoholic fatty liver disease patients: a case - control study","volume":"16","author":"Feng","year":"2017","journal-title":"Lipids Health Dis."},{"issue":"7","key":"10.1016\/j.bbadis.2022.166480_bb0165","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/nrgastro.2017.38","article-title":"Mechanisms of hepatic stellate cell activation","volume":"14","author":"Tsuchida","year":"2017","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"11","key":"10.1016\/j.bbadis.2022.166480_bb0170","doi-asserted-by":"crossref","DOI":"10.3390\/cells8111419","article-title":"TGF-beta in hepatic stellate cell activation and liver fibrogenesis-updated 2019","volume":"8","author":"Dewidar","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.bbadis.2022.166480_bb0175","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.ejmech.2018.09.068","article-title":"Development of 2-amino-4-phenylthiazole analogues to disrupt myeloid differentiation factor 88 and prevent inflammatory responses in acute lung injury","volume":"161","author":"Chen","year":"2019","journal-title":"Eur. J. Med. Chem."},{"issue":"1","key":"10.1016\/j.bbadis.2022.166480_bb0180","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1097\/FJC.0000000000000846","article-title":"Inhibition of MyD88 by LM8 attenuates obesity-induced cardiac injury","volume":"76","author":"Liu","year":"2020","journal-title":"J. Cardiovasc. Pharmacol."},{"issue":"4","key":"10.1016\/j.bbadis.2022.166480_bb0185","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1002\/hep.23122","article-title":"Toll-like receptor 4 is involved in the development of fructose-induced hepatic steatosis in mice","volume":"50","author":"Spruss","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.bbadis.2022.166480_bb0190","doi-asserted-by":"crossref","first-page":"13997","DOI":"10.1038\/ncomms13997","article-title":"Saturated palmitic acid induces myocardial inflammatory injuries through direct binding to TLR4 accessory protein MD2","volume":"8","author":"Wang","year":"2017","journal-title":"Nat. Commun."},{"issue":"2","key":"10.1016\/j.bbadis.2022.166480_bb0195","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1002\/hep.26081","article-title":"Toll-like receptor 2 and palmitic acid cooperatively contribute to the development of nonalcoholic steatohepatitis through inflammasome activation in mice","volume":"57","author":"Miura","year":"2013","journal-title":"Hepatology"},{"issue":"9","key":"10.1016\/j.bbadis.2022.166480_bb0200","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1111\/liv.12537","article-title":"Both bone marrow-derived and non-bone marrow-derived cells contribute to AIM2 and NLRP3 inflammasome activation in a MyD88-dependent manner in dietary steatohepatitis","volume":"34","author":"Csak","year":"2014","journal-title":"Liver Int."},{"issue":"9","key":"10.1016\/j.bbadis.2022.166480_bb0205","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1004368","article-title":"Hematopoietic but not endothelial cell MyD88 contributes to host defense during gram-negative pneumonia derived sepsis","volume":"10","author":"van Lieshout","year":"2014","journal-title":"PLoS Pathog."},{"issue":"5","key":"10.1016\/j.bbadis.2022.166480_bb0210","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1038\/nri.2017.11","article-title":"Liver macrophages in tissue homeostasis and disease","volume":"17","author":"Krenkel","year":"2017","journal-title":"Nat. Rev. Immunol."},{"issue":"4","key":"10.1016\/j.bbadis.2022.166480_bb0215","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.immuni.2019.09.002","article-title":"Liver-derived signals sequentially reprogram myeloid enhancers to initiate and maintain kupffer cell identity","volume":"51","author":"Sakai","year":"2019","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.bbadis.2022.166480_bb0220","doi-asserted-by":"crossref","first-page":"356","DOI":"10.4049\/jimmunol.1502301","article-title":"Characterization of the inflammasome in human kupffer cells in response to synthetic agonists and pathogens","volume":"197","author":"Zannetti","year":"2016","journal-title":"J. Immunol."},{"issue":"5","key":"10.1016\/j.bbadis.2022.166480_bb0225","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1517\/14728222.2016.1125883","article-title":"Pathophysiological mechanisms and therapeutic potentials of macrophages in non-alcoholic steatohepatitis","volume":"20","author":"Wu","year":"2016","journal-title":"Expert Opin. Ther. Targets"},{"issue":"4","key":"10.1016\/j.bbadis.2022.166480_bb0230","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1002\/hep.26429","article-title":"Hepatic macrophages but not dendritic cells contribute to liver fibrosis by promoting the survival of activated hepatic stellate cells in mice","volume":"58","author":"Pradere","year":"2013","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.bbadis.2022.166480_bb0235","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1136\/gutjnl-2015-310904","article-title":"Hepatocyte MyD88 affects bile acids, gut microbiota and metabolome contributing to regulate glucose and lipid metabolism","volume":"66","author":"Duparc","year":"2017","journal-title":"Gut"},{"issue":"9","key":"10.1016\/j.bbadis.2022.166480_bb0240","doi-asserted-by":"crossref","first-page":"3612","DOI":"10.1021\/jm401006s","article-title":"Toll-like receptor 4 (TLR4) modulation by synthetic and natural compounds: an update","volume":"57","author":"Peri","year":"2014","journal-title":"J. Med. Chem."},{"issue":"2","key":"10.1016\/j.bbadis.2022.166480_bb0245","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1038\/s41401-021-00766-6","article-title":"Pharmacological inhibition of MyD88 suppresses inflammation in tubular epithelial cells and prevents diabetic nephropathy in experimental mice","volume":"43","author":"Zhang","year":"2022","journal-title":"Acta Pharmacol. Sin."},{"issue":"11","key":"10.1016\/j.bbadis.2022.166480_bb0250","doi-asserted-by":"crossref","first-page":"4239","DOI":"10.1172\/JCI81203","article-title":"STK4 regulates TLR pathways and protects against chronic inflammation-related hepatocellular carcinoma","volume":"125","author":"Li","year":"2015","journal-title":"J. Clin. Invest."},{"issue":"2","key":"10.1016\/j.bbadis.2022.166480_bb0255","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1002\/hep.27841","article-title":"Damage-associated molecular pattern-activated neutrophil extracellular trap exacerbates sterile inflammatory liver injury","volume":"62","author":"Huang","year":"2015","journal-title":"Hepatology (Baltimore, Md)"},{"issue":"10","key":"10.1016\/j.bbadis.2022.166480_bb0260","doi-asserted-by":"crossref","first-page":"5392","DOI":"10.4049\/jimmunol.165.10.5392","article-title":"Cutting edge: TLR2-deficient and MyD88-deficient mice are highly susceptible to Staphylococcus aureus infection","volume":"165","author":"Takeuchi","year":"2000","journal-title":"J. Immunol."},{"issue":"12","key":"10.1016\/j.bbadis.2022.166480_bb0265","doi-asserted-by":"crossref","first-page":"5997","DOI":"10.4049\/jimmunol.168.12.5997","article-title":"Cutting edge: MyD88 is required for resistance to Toxoplasma gondii infection and regulates parasite-induced IL-12 production by dendritic cells","volume":"168","author":"Scanga","year":"2002","journal-title":"J. Immunol."}],"container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092544392200151X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092544392200151X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T05:11:30Z","timestamp":1760418690000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S092544392200151X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":53,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["S092544392200151X"],"URL":"https:\/\/doi.org\/10.1016\/j.bbadis.2022.166480","relation":{},"ISSN":["0925-4439"],"issn-type":[{"value":"0925-4439","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Macrophage-specific MyD88 deletion and pharmacological inhibition prevents liver damage in non-alcoholic fatty liver disease via reducing inflammatory response","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbadis.2022.166480","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"166480"}}